111, Inc. (YI): Price and Financial Metrics


111, Inc. (YI): $2.87

0.01 (+0.35%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add YI to Watchlist
Sign Up

Industry: China


Ranked

of

in industry

YI Stock Price Chart Interactive Chart >

Price chart for YI

YI Price/Volume Stats

Current price $2.87 52-week high $4.17
Prev. close $2.86 52-week low $1.37
Day low $2.84 Volume 84,900
Day high $2.90 Avg. volume 378,981
50-day MA $2.80 Dividend yield N/A
200-day MA $2.50 Market Cap 237.28M

111, Inc. (YI) Company Bio


111, Inc. operates an integrated online and offline platform in the healthcare market in the People's Republic of China. The company sells medical and wellness products through online retail, and wholesale and retail pharmacies, as well as provides value-added services, such as online consultation services and e-prescription services to consumers. It also offers a suite of cloud-based solutions and Internet-based software services, including the provision of access to business applications and service modules, such as customer relationship management, supply chain management, online medical consultation, e-prescriptions, digital contract sales organization, and precision marketing. In addition, the company is involved in warehousing, logistics, procurement, research and development, and consulting activities; and software development and information technology support businesses. As of June 30, 2018, 111, Inc. had a network of 12 offline retail pharmacies branded as Yi Hao Pharmacy in Guangzhou, Shanghai, Tianjin, and Kunshan. It services pharmacies, pharmaceutical companies, medical professionals and consumers. The company was formerly known as New Peak Group and changed its name to 111, Inc. in April 2018. 111, Inc. was founded in 2012 and is based in Shanghai, China.


YI Latest News Stream


Event/Time News Detail
Loading, please wait...

YI Latest Social Stream


Loading social stream, please wait...

View Full YI Social Stream

Latest YI News From Around the Web

Below are the latest news stories about 111 INC that investors may wish to consider to help them evaluate YI as an investment opportunity.

111, Inc. Announces Appointment of Independent Financial Advisor and Legal Counsel to the Special Committee

111, Inc. ( "111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company in China, announced today that the special committee (the "Special Committee"), consisting of three independent directors, Mr. Jian Sun, who is the chairman of the Special Committee, Mr. Nee Chuan Teo and Mr. Jun Luo, established by the Company's Board of Directors (the "Board") has retained Houlihan Lokey China Limited as its independent financial advisor and Kirkland & Ellis as its U.S. legal c

Yahoo | September 23, 2022

111 Inc. Receives Unsolicited Preliminary Non-Binding Proposal to Acquire the Company

111 Inc. ( "111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company in China, today announced that its Board of Directors (the "Board") has received an unsolicited preliminary non-binding proposal letter (the "Proposal") dated September 9, 2022 jointly submitted by Dr. Gang Yu, co-founder and co-chairman of the Company, Mr. Junling Liu, cofounder, co-chairman and chief executive officer of the Company (collectively, the "Co- Founders") and Shanghai Guosheng Capita

Yahoo | September 9, 2022

111, Inc. Announces Second Quarter 2022 Unaudited Financial Results

111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine and healthcare services in China, today announced its unaudited financial results for the second quarter ended June 30, 2022.

Yahoo | August 25, 2022

What You Need To Know About 111, Inc.'s (NASDAQ:YI) Investor Composition

The big shareholder groups in 111, Inc. ( NASDAQ:YI ) have power over the company. Large companies usually have...

Yahoo | August 8, 2022

111 to Announce Second Quarter 2022 Unaudited Financial Results on August 25, 2022 - Conference Call to Follow

111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine and healthcare services in China, today announced that it will report its unaudited financial results for the second quarter ended June 30, 2022, before the U.S. market opens on Thursday, August 25, 2022.

Yahoo | August 5, 2022

Read More 'YI' Stories Here

YI Price Returns

1-mo 9.96%
3-mo -2.05%
6-mo 33.49%
1-year -27.89%
3-year -43.84%
5-year N/A
YTD -18.00%
2021 -49.64%
2020 3.27%
2019 9.61%
2018 N/A
2017 N/A

Continue Researching YI

Want to do more research on 111 Inc's stock and its price? Try the links below:

111 Inc (YI) Stock Price | Nasdaq
111 Inc (YI) Stock Quote, History and News - Yahoo Finance
111 Inc (YI) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.7561 seconds.